1140 related articles for article (PubMed ID: 25486076)
21. Stereotactic radiosurgery and stereotactic radiotherapy in the treatment of skull base meningiomas.
McGregor JM; Sarkar A
Otolaryngol Clin North Am; 2009 Aug; 42(4):677-88. PubMed ID: 19751872
[TBL] [Abstract][Full Text] [Related]
22. [Skull base meningiomas: a predictive system to know the extent of their surgical resection and patient outcome].
Morales F; Maillo A; Díaz-Alvarez A; Merino M; Muñoz-Herrera A; Hernández J; Santamarta D
Neurocirugia (Astur); 2005 Dec; 16(6):477-85. PubMed ID: 16378129
[TBL] [Abstract][Full Text] [Related]
23. Early postoperative radiotherapy improves progression free survival in patients with grade 2 meningioma.
Aboukais R; Baroncini M; Zairi F; Reyns N; Lejeune JP
Acta Neurochir (Wien); 2013 Aug; 155(8):1385-90; discussion 1390. PubMed ID: 23728501
[TBL] [Abstract][Full Text] [Related]
24. True petroclival meningiomas: results of surgical management.
Almefty R; Dunn IF; Pravdenkova S; Abolfotoh M; Al-Mefty O
J Neurosurg; 2014 Jan; 120(1):40-51. PubMed ID: 24160473
[TBL] [Abstract][Full Text] [Related]
25. Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation.
Aghi MK; Carter BS; Cosgrove GR; Ojemann RG; Amin-Hanjani S; Martuza RL; Curry WT; Barker FG
Neurosurgery; 2009 Jan; 64(1):56-60; discussion 60. PubMed ID: 19145156
[TBL] [Abstract][Full Text] [Related]
26. Clinical outcome after particle therapy for meningiomas of the skull base: toxicity and local control in patients treated with active rasterscanning.
El Shafie RA; Czech M; Kessel KA; Habermehl D; Weber D; Rieken S; Bougatf N; Jäkel O; Debus J; Combs SE
Radiat Oncol; 2018 Mar; 13(1):54. PubMed ID: 29587795
[TBL] [Abstract][Full Text] [Related]
27. Differential Tumor Progression Patterns in Skull Base Versus Non-Skull Base Meningiomas: A Critical Analysis from a Long-Term Follow-Up Study and Review of Literature.
Savardekar AR; Patra DP; Bir S; Thakur JD; Mohammed N; Bollam P; Georgescu MM; Nanda A
World Neurosurg; 2018 Apr; 112():e74-e83. PubMed ID: 29258946
[TBL] [Abstract][Full Text] [Related]
28. Treatment of atypical meningioma.
Jo K; Park HJ; Nam DH; Lee JI; Kong DS; Park K; Kim JH
J Clin Neurosci; 2010 Nov; 17(11):1362-6. PubMed ID: 20800497
[TBL] [Abstract][Full Text] [Related]
29. Long-Term Outcomes of Newly Diagnosed Resected Atypical Meningiomas and the Role of Adjuvant Radiotherapy.
Zhi M; Girvigian MR; Miller MJ; Chen JC; Schumacher AJ; Rahimian J; Lodin K
World Neurosurg; 2019 Feb; 122():e1153-e1161. PubMed ID: 30447464
[TBL] [Abstract][Full Text] [Related]
30. Gross total resection and adjuvant radiotherapy most significant predictors of improved survival in patients with atypical meningioma.
Rydzewski NR; Lesniak MS; Chandler JP; Kalapurakal JA; Pollom E; Tate MC; Bloch O; Kruser T; Dalal P; Sachdev S
Cancer; 2018 Feb; 124(4):734-742. PubMed ID: 29131312
[TBL] [Abstract][Full Text] [Related]
31. Surgically resected skull base meningiomas demonstrate a divergent postoperative recurrence pattern compared with non-skull base meningiomas.
Mansouri A; Klironomos G; Taslimi S; Kilian A; Gentili F; Khan OH; Aldape K; Zadeh G
J Neurosurg; 2016 Aug; 125(2):431-40. PubMed ID: 26722844
[TBL] [Abstract][Full Text] [Related]
32. Skull Base Meningiomas: Is Surgical Resection Enough? Outcome Evaluation and Prognostic Factors Analysis in a Single-Center Cohort.
Pessina F; Navarria P; Rossini Z; Clerici E; Fornari M; Politi LS; Scorsetti M; Servadei F
J Neurol Surg A Cent Eur Neurosurg; 2022 Nov; 83(6):516-522. PubMed ID: 34897619
[TBL] [Abstract][Full Text] [Related]
33. Clinical, Radiologic, and Pathologic Features of 56 Cases of Intracranial Lymphoplasmacyte-Rich Meningioma.
Tao X; Wang K; Dong J; Hou Z; Wu Z; Zhang J; Liu B
World Neurosurg; 2017 Oct; 106():152-164. PubMed ID: 28673887
[TBL] [Abstract][Full Text] [Related]
34. Surgical management and outcomes of petroclival meningiomas: a single-center case series of 259 patients.
Li D; Hao SY; Wang L; Tang J; Xiao XR; Zhou H; Jia GJ; Wu Z; Zhang LW; Zhang JT
Acta Neurochir (Wien); 2013 Aug; 155(8):1367-83. PubMed ID: 23801089
[TBL] [Abstract][Full Text] [Related]
35. Risk group-adapted adjuvant radiotherapy for WHO grade I and II skull base meningioma.
Park S; Cha YJ; Suh SH; Lee IJ; Lee KS; Hong CK; Kim JW
J Cancer Res Clin Oncol; 2019 May; 145(5):1351-1360. PubMed ID: 30953136
[TBL] [Abstract][Full Text] [Related]
36. Outcomes following myxopapillary ependymoma resection: the importance of capsule integrity.
Abdulaziz M; Mallory GW; Bydon M; De la Garza Ramos R; Ellis JA; Laack NN; Marsh WR; Krauss WE; Jallo G; Gokaslan ZL; Clarke MJ
Neurosurg Focus; 2015 Aug; 39(2):E8. PubMed ID: 26235025
[TBL] [Abstract][Full Text] [Related]
37. Olfactory groove meningioma: discussion of clinical presentation and surgical outcomes following excision via the subcranial approach.
Pepper JP; Hecht SL; Gebarski SS; Lin EM; Sullivan SE; Marentette LJ
Laryngoscope; 2011 Nov; 121(11):2282-9. PubMed ID: 21994142
[TBL] [Abstract][Full Text] [Related]
38. Evolution and future of skull base surgery: the paradigm of skull base meningiomas.
Di Maio S; Ramanathan D; Garcia-Lopez R; Rocha MH; Guerrero FP; Ferreira M; Sekhar LN
World Neurosurg; 2012; 78(3-4):260-75. PubMed ID: 22120278
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma.
Zhu H; Bi WL; Aizer A; Hua L; Tian M; Den J; Tang H; Chen H; Wang Y; Mao Y; Dunn IF; Xie Q; Gong Y
Cancer Med; 2019 Jan; 8(1):13-20. PubMed ID: 30680963
[TBL] [Abstract][Full Text] [Related]
40. Progesterone receptor expression and prediction of benefits of adjuvant radiotherapy in de novo atypical meningiomas after gross-total resection.
Ren L; Cheng H; Chen J; Deng J; Wang D; Xie Q; Wakimoto H; Hua L; Gong Y
J Neurosurg; 2023 Jul; 139(1):49-58. PubMed ID: 36334291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
